𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclin-D1 expression in human renal-cell carcinoma

✍ Scribed by Ylva Hedberg; Estela Davoodi; Göran Roos; Börje Ljungberg; Göran Landberg

Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
162 KB
Volume
84
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Cyclin-D1 over-expression represents one of several common alterations in the G 1 -S transition associated with malignancies. Conclusive evidences indicate that cyclin D1 is a proto-oncogene and the gene is amplified or rearranged in different tumour types. Since very little is known about aberrations in the G 1 -S transition in human renal-cell carcinoma (RCC), we have characterized the expression of cyclin D1 in 80 human renal-cell carcinomas and 12 normal kidney cortex tissues using Western blotting. The cyclin-D1-protein content varied considerably and 75% of the tumours expressed higher levels than normal kidney cortex, in contrast to 25% of the tumours either lacking cyclin D1 or with low protein levels. Although it is difficult to define aberrant expression of cyclin D1, the results might indicate that the proto-oncogene was activated in a sub-set of RCC. It is also possible that low expression of cyclin D1 represents an aberrant down-regulation of the protein. Immunohistochemical assessment of cyclin D1 in a sub-set of the tumours showed large variations in the fraction of cyclin-D1-positive cells, supporting the Western-blot analyses. Surprisingly, cyclin-D1 expression did not correlate with proliferation determined by Ki-67-antigen expression or S-phase analyses. In non-papillary renal-cell carcinomas, high cyclin-D1 expression was associated with a diploid DNA profile and smaller tumour size, but there was no association between cyclin-D1 expression and tumour stage or nuclear grade. In nonpapillary tumours, high cyclin-D1 expression was further significantly associated with a better prognosis according to univariate and multivariate analyses (p ‫؍‬ 0.005 and 0.002 respectively), as compared with highly aggressive tumours with low cyclin-D1 levels.

📜 SIMILAR VOLUMES

Cyclin D1 expression in human prostate c
Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors
✍ Han, Edward Kyu-Ho; Lim, Jin T.E.; Arber, Nadir; Rubin, Mark A.; Xing, Wang Qiu; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 2 views

## BACKGROUND. The cyclin D1 gene is amplified and/or overexpressed in several types of human cancer, including cancers of the breast, esophagus, head, and neck. However, the role of cyclin D1 in prostate cancer has not been previously studied in detail. METHODS. Six human prostate cancer cell lin

Cyclin D1 in mammary carcinoma
Cyclin D1 in mammary carcinoma
✍ Barnes, Diana M. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

The control of the cell-cycle-associated protein cyclin D1 and its variable behaviour in normal and transformed cells is described and contrasted with its activity in vivo. The role of cyclin D1 as a prognostic and predictive marker is examined in clinical breast cancer. High levels of the protein a

Tiam1 mutations in human renal-cell carc
Tiam1 mutations in human renal-cell carcinomas
✍ Rainer Engers; Thomas P. Zwaka; Lutz Gohr; Achim Weber; Claus-Dieter Gerharz; He 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 199 KB 👁 2 views
Overexpression of cyclin D1 is rare in h
Overexpression of cyclin D1 is rare in human prostate carcinoma
✍ Gumbiner, Laura M.; Gumerlock, Paul H.; Mack, Philip C.; Chi, Sung-Gil; deVere W 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

## Background: Overexpression of cyclin d1 has been documented in a number of human cancers. increased expression of cyclin d1 can contribute to cellular transformation and abnormal proliferation. ## Methods: Quantitative rt-pcr and/or western blot analysis were used to determine the level of cyc